Corporate Announcements

AstraZeneca Q2 Results Show 37% Growth Driven by Oncology and Biopharmaceuticals

AstraZeneca Pharma India Limited announced a 37% revenue growth for the quarter ended September 30, 2025, driven by strong performance in Oncology and Biopharmaceuticals....

Aegis Logistics Audio Recording of Earnings Call on November 7, 2025

Aegis Logistics announces the availability of the audio recording of its earnings call discussing the unaudited financial results for the quarter and six months...

Ramkrishna Forgings Receives Tribunal Order for Amalgamation Scheme

Ramkrishna Forgings announced that the National Company Law Tribunal (NCLT), Kolkata Bench, has approved the Second Motion Petition Order regarding the Scheme of Amalgamation....

Samvardhana Motherson Establishes Motherson ESOP Trust

Samvardhana Motherson International Limited has established the Motherson ESOP Trust to manage its employee stock option scheme. The trust, formed with an initial corpus...

Kotak Mahindra Bank Clarification on Volume Movement in Bank’s Securities

Kotak Mahindra Bank has responded to queries regarding significant volume fluctuations in its securities trading. The bank affirms adherence to disclosure norms and clarifies...

Zydus Lifesciences Receives Tentative USFDA Approval for Olaparib Tablets

Zydus Lifesciences has received tentative approval from the USFDA for Olaparib Tablets, 100 mg and 150 mg. These tablets are indicated for the treatment...

Global Health Strong Q2 FY2026 Results Driven by Volume and Realization Growth

Global Health (Medanta) reported a 15% year-over-year revenue growth and a 14% year-over-year EBITDA increase (excluding Noida) for Q2 FY2026. Key drivers include increased...

NALCO Earnings Call Scheduled for Today, November 7, 2025

NALCO (National Aluminium Company Limited) is holding an earnings call today, November 7, 2025, to discuss the company's business performance and outlook following the...

Torrent Pharmaceuticals Unaudited Consolidated Financial Results for Q2 & H1 2026

Torrent Pharmaceuticals has announced its unaudited consolidated financial results for the quarter and half-year ended September 30, 2025. The company reported a total revenue...

Latest articles